In contrast, Plk2 is also reported as an oncogenic factor based on its overexpression and tumor-promoting effects in colorectal cancer, bladder cancer, and pancreatic cancer (Kothari et al. 2013; Ou et al. 2016; Tan et al. 2010). This evidence concerns the gene PLK2 and urinary bladder carcinoma.